Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Natalie Landon-Brace

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Advanced Healthcare Materials|August 17, 2023
Exploring New Dimensions of Tumor Heterogeneity: The Application of Single Cell Analysis to Organoid-Based 3D In Vitro ModelsNatalie Landon-Brace, Nancy T Li, Alison P McGuigan
Optometry and Vision Science : Official Publication of the American Academy of Optometry|July 25, 2015
Identifying Absolute Preferred Retinal Locations during Binocular ViewingLuminita Tarita-Nistor, Moshe Eizenman, Natalie Landon-Brace, et al.
Advanced Healthcare Materials|October 29, 2022
An Engineered Paper-Based 3D Coculture Model of Pancreatic Cancer to Study the Impact of Tissue Architecture and Microenvironmental Gradients on Cell PhenotypeJose L Cadavid, Simon Latour, Ferris Nowlan, et al.
Biomaterials|November 7, 2022
An off-the-shelf multi-well scaffold-supported platform for tumour organoid-based tissuesNancy T Li, Nila C Wu, Ruonan Cao, et al.
Scientific Reports|September 9, 2025
Correction: Analysis of an engineered organoid model of pancreatic cancer identifies hypoxia as a contributing factor in determining transcriptional subtypesNatalie Landon-Brace, Simon Latour, Brendan T Innes, et al.
Scientific Reports|July 3, 2025
Analysis of an engineered organoid model of pancreatic cancer identifies hypoxia as a contributing factor in determining transcriptional subtypesNatalie Landon-Brace, Simon Latour, Brendan T Innes, et al.
Nature Biomedical Engineering|August 9, 2019
A resistance-sensing mechanical injector for the precise delivery of liquids to target tissueGirish D Chitnis, Mohan K S Verma, Julien Lamazouade, et al.
Molecular Cancer Therapeutics|December 5, 2020
Cabozantinib Unlocks Efficient <i>In Vivo</i> Targeted Delivery of Neutrophil-Loaded Nanoparticles into Murine Prostate TumorsKiranj Kishor Chaudagar, Natalie Landon-Brace, Aniruddh Solanki, et al.
Oncotarget|August 4, 2016
A role for activated Cdc42 in glioblastoma multiforme invasionHidehiro Okura, Brian J Golbourn, Uswa Shahzad, et al.
Cancer Discovery|March 10, 2017
Cabozantinib Eradicates Advanced Murine Prostate Cancer by Activating Antitumor Innate ImmunityAkash Patnaik, Kenneth D Swanson, Eva Csizmadia, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Advanced Healthcare Materials|August 17, 2023
Exploring New Dimensions of Tumor Heterogeneity: The Application of Single Cell Analysis to Organoid-Based 3D In Vitro ModelsNatalie Landon-Brace, Nancy T Li, Alison P McGuigan
Optometry and Vision Science : Official Publication of the American Academy of Optometry|July 25, 2015
Identifying Absolute Preferred Retinal Locations during Binocular ViewingLuminita Tarita-Nistor, Moshe Eizenman, Natalie Landon-Brace, et al.
Advanced Healthcare Materials|October 29, 2022
An Engineered Paper-Based 3D Coculture Model of Pancreatic Cancer to Study the Impact of Tissue Architecture and Microenvironmental Gradients on Cell PhenotypeJose L Cadavid, Simon Latour, Ferris Nowlan, et al.
Biomaterials|November 7, 2022
An off-the-shelf multi-well scaffold-supported platform for tumour organoid-based tissuesNancy T Li, Nila C Wu, Ruonan Cao, et al.
Scientific Reports|September 9, 2025
Correction: Analysis of an engineered organoid model of pancreatic cancer identifies hypoxia as a contributing factor in determining transcriptional subtypesNatalie Landon-Brace, Simon Latour, Brendan T Innes, et al.
Scientific Reports|July 3, 2025
Analysis of an engineered organoid model of pancreatic cancer identifies hypoxia as a contributing factor in determining transcriptional subtypesNatalie Landon-Brace, Simon Latour, Brendan T Innes, et al.
Nature Biomedical Engineering|August 9, 2019
A resistance-sensing mechanical injector for the precise delivery of liquids to target tissueGirish D Chitnis, Mohan K S Verma, Julien Lamazouade, et al.
Molecular Cancer Therapeutics|December 5, 2020
Cabozantinib Unlocks Efficient <i>In Vivo</i> Targeted Delivery of Neutrophil-Loaded Nanoparticles into Murine Prostate TumorsKiranj Kishor Chaudagar, Natalie Landon-Brace, Aniruddh Solanki, et al.
Oncotarget|August 4, 2016
A role for activated Cdc42 in glioblastoma multiforme invasionHidehiro Okura, Brian J Golbourn, Uswa Shahzad, et al.
Cancer Discovery|March 10, 2017
Cabozantinib Eradicates Advanced Murine Prostate Cancer by Activating Antitumor Innate ImmunityAkash Patnaik, Kenneth D Swanson, Eva Csizmadia, et al.
Pageof 2